These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. ENDOPHTHALMITIS CAUSED BY PSEUDOMONAS AERUGINOSA: Clinical Features, Antibiotic Susceptibilities, and Treatment Outcomes. Sridhar J; Kuriyan AE; Flynn HW; Miller D Retina; 2015 Jun; 35(6):1101-6. PubMed ID: 25658178 [TBL] [Abstract][Full Text] [Related]
14. Clinical features, microbiological profile and treatment outcome of patients with Corynebacterium endophthalmitis: review of a decade from a tertiary eye care centre in southern India. Joseph J; Nirmalkar K; Mathai A; Sharma S Br J Ophthalmol; 2016 Feb; 100(2):189-94. PubMed ID: 26124461 [TBL] [Abstract][Full Text] [Related]
15. Clinical Features, Antibiotic Susceptibilities, and Treatment Outcomes of Endophthalmitis Caused by Staphylococcus epidermidis. Yannuzzi NA; Patel NA; Relhan N; Tran KD; Si N; Albini TA; Berrocal AM; Davis JL; Smiddy WE; Townsend J; Miller D; Flynn HW Ophthalmol Retina; 2018 May; 2(5):396-400. PubMed ID: 31047321 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of intravitreal piperacillin/tazobactam in rabbits with experimental Staphylococcus epidermidis endophthalmitis: a comparison with vancomycin. Ozkiriş A; Evereklioglu C; Eşel D; Akgün H; Erkiliç K Ophthalmic Res; 2005; 37(3):168-74. PubMed ID: 15942265 [TBL] [Abstract][Full Text] [Related]
18. Endophthalmitis caused by enterococcus faecalis: antibiotic selection and treatment outcomes. Scott IU; Loo RH; Flynn HW; Miller D Ophthalmology; 2003 Aug; 110(8):1573-7. PubMed ID: 12917175 [TBL] [Abstract][Full Text] [Related]